Susquehanna International Group
SUPN icon

Susquehanna International Group’s Supernus Pharmaceuticals SUPN Stock Holding History

Susquehanna International Group’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$925K Buy
17,900
+10,700
+149% +$545K ﹤0.01% 8084
2025
Q4 		$358K Sell
7,200
-3,900
-35% -$190K ﹤0.01% 9534
2025
Q3 		$530K Buy
+11,100
New +$447K ﹤0.01% 8798
2025
Q1 		– Sell
-10,200
Closed -$369K – 13423
2024
Q4 		$369K Sell
10,200
-2,500
-20% -$88K ﹤0.01% 9371
2024
Q3 		$396K Sell
12,700
-4,600
-27% -$144K ﹤0.01% 9013
2024
Q2 		$463K Sell
17,300
-38,500
-69% -$1.12M ﹤0.01% 8452
2024
Q1 		$1.9M Buy
55,800
+39,000
+232% +$1.16M ﹤0.01% 5460
2023
Q4 		$486K Buy
16,800
+700
+4% +$18.6K ﹤0.01% 8728
2023
Q3 		$444K Buy
16,100
+1,700
+12% +$51.7K ﹤0.01% 8509
2023
Q2 		$433K Sell
14,400
-4,100
-22% -$143K ﹤0.01% 8651
2023
Q1 		$670K Buy
18,500
+1,300
+8% +$50K ﹤0.01% 7829
2022
Q4 		$614K Sell
17,200
-13,100
-43% -$455K ﹤0.01% 7328
2022
Q3 		$1.03M Sell
30,300
-6,400
-17% -$208K ﹤0.01% 6576
2022
Q2 		$1.06M Sell
36,700
-2,800
-7% -$80.2K ﹤0.01% 6383
2022
Q1 		$1.28M Buy
39,500
+1,200
+3% +$36.8K ﹤0.01% 6526
2021
Q4 		$1.12M Buy
38,300
+12,100
+46% +$367K ﹤0.01% 7007
2021
Q3 		$699K Buy
26,200
+5,200
+25% +$140K ﹤0.01% 8516
2021
Q2 		$647K Sell
21,000
-17,600
-46% -$540K ﹤0.01% 8936
2021
Q1 		$1.01M Buy
38,600
+19,900
+106% +$557K ﹤0.01% 7714
2020
Q4 		$470K Sell
18,700
-4,400
-19% -$94.7K ﹤0.01% 8418
2020
Q3 		$481K Buy
23,100
+12,900
+126% +$293K ﹤0.01% 7763
2020
Q2 		$242K Sell
10,200
-11,300
-53% -$250K ﹤0.01% 8711
2020
Q1 		$387K Sell
21,500
-52,100
-71% -$1.09M ﹤0.01% 7475
2019
Q4 		$1.75M Buy
73,600
+6,000
+9% +$146K ﹤0.01% 4554
2019
Q3 		$1.86M Sell
67,600
-81,600
-55% -$2.42M ﹤0.01% 4361
2019
Q2 		$4.94M Buy
149,200
+15,200
+11% +$521K ﹤0.01% 2726
2019
Q1 		$4.7M Buy
134,000
+11,400
+9% +$424K ﹤0.01% 2532
2018
Q4 		$4.07M Buy
122,600
+5,600
+5% +$241K ﹤0.01% 2535
2018
Q3 		$5.89M Buy
117,000
+46,000
+65% +$2.27M ﹤0.01% 2489
2018
Q2 		$4.25M Buy
71,000
+9,400
+15% +$487K ﹤0.01% 2926
2018
Q1 		$2.82M Buy
61,600
+18,300
+42% +$764K ﹤0.01% 3345
2017
Q4 		$1.73M Sell
43,300
-7,200
-14% -$285K ﹤0.01% 4170
2017
Q3 		$2.02M Sell
50,500
-60,800
-55% -$2.63M ﹤0.01% 3890
2017
Q2 		$4.8M Buy
111,300
+16,500
+17% +$587K ﹤0.01% 2463
2017
Q1 		$2.97M Buy
94,800
+78,800
+493% +$2.11M ﹤0.01% 3044
2016
Q4 		$404K Sell
16,000
-8,900
-36% -$199K ﹤0.01% 7417
2016
Q3 		$616K Sell
24,900
-72,700
-74% -$1.65M ﹤0.01% 5679
2016
Q2 		$1.99M Sell
97,600
-49,700
-34% -$882K ﹤0.01% 3582
2016
Q1 		$2.25M Buy
147,300
+56,600
+62% +$739K ﹤0.01% 3561
2015
Q4 		$1.22M Buy
90,700
+2,600
+3% +$40.2K ﹤0.01% 5024
2015
Q3 		$1.24M Buy
88,100
+22,000
+33% +$409K ﹤0.01% 5251
2015
Q2 		$1.12M Sell
66,100
-5,600
-8% -$79.7K ﹤0.01% 5966
2015
Q1 		$867K Sell
71,700
-61,100
-46% -$577K ﹤0.01% 6046
2014
Q4 		$1.1M Buy
132,800
+13,300
+11% +$112K ﹤0.01% 5677
2014
Q3 		$1.04M Sell
119,500
-68,500
-36% -$619K ﹤0.01% 5845
2014
Q2 		$2.06M Buy
188,000
+99,400
+112% +$886K ﹤0.01% 4599
2014
Q1 		$792K Sell
88,600
-42,300
-32% -$390K ﹤0.01% 5938
2013
Q4 		$987K Sell
130,900
-711,700
-84% -$4.98M ﹤0.01% 5539
2013
Q3 		$6.18M Buy
842,600
+606,400
+257% +$4.07M ﹤0.01% 2442
2013
Q2 		$1.52M Buy
+236,200
New +$1.39M ﹤0.01% 4340

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's SUPN Position: Q1 2026 in Review

Susquehanna International Group reduced its Supernus Pharmaceuticals (SUPN) stake by 2.9% in Q1 2026, selling an estimated $62.8K and leaving 40,750 shares worth $2.11M. The position accounts for ﹤0.01% of the portfolio, ranked #6062.

Susquehanna International Group first reported a position in SUPN in Q2 2013 and has held it in 47 quarters since. The position peaked at $4.5M in Q4 2016. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Susquehanna International Group held 40,750 shares of Supernus Pharmaceuticals worth $2.11M as of Q1 2026.
  • Susquehanna International Group sold 1,234 Supernus Pharmaceuticals shares in Q1 2026, an estimated $62.8K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6062 holding.
  • Susquehanna International Group first reported a position in Supernus Pharmaceuticals in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's Supernus Pharmaceuticals position peaked at $4.5M in Q4 2016.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.